Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,906,130
-
Share change
-
-593,494
-
Total reported value
-
$25,632,676
-
Price per share
-
$0.73
-
Number of holders
-
60
-
Value change
-
-$2,728,955
-
Number of buys
-
28
-
Number of sells
-
29
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q4 2018
As of 31 Dec 2018,
CTI BIOPHARMA CORP - COM (CTIC) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,906,130 shares.
The largest 10 holders included
BVF INC/IL, Stonepine Capital Management, LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, BlackRock Inc., Vanguard Group Inc, Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and Balyasny Asset Management LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.